| Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression F Hieronymus, JF Emilsson, S Nilsson, E Eriksson Molecular psychiatry 21 (4), 523-530, 2016 | 254 | 2016 |
| A mega-analysis of fixed-dose trials reveals dose-dependency and a rapid onset of action for the antidepressant effect of three selective serotonin reuptake inhibitors F Hieronymus, S Nilsson, E Eriksson Translational psychiatry 6 (6), e834-e834, 2016 | 116 | 2016 |
| The efficacy of repetitive transcranial magnetic stimulation (rTMS) for bipolar depression: a systematic review and meta-analysis TD Nguyen, F Hieronymus, R Lorentzen, A McGirr, SD Østergaard Journal of Affective Disorders 279, 250-255, 2021 | 99 | 2021 |
| The efficacy of transcranial magnetic stimulation (TMS) for negative symptoms in schizophrenia: a systematic review and meta-analysis R Lorentzen, TD Nguyen, A McGirr, F Hieronymus, SD Østergaard Schizophrenia 8 (1), 35, 2022 | 90 | 2022 |
| Influence of baseline severity on the effects of SSRIs in depression: an item-based, patient-level post-hoc analysis F Hieronymus, A Lisinski, S Nilsson, E Eriksson The Lancet Psychiatry 6 (9), 745-752, 2019 | 85 | 2019 |
| Efficacy of selective serotonin reuptake inhibitors in the absence of side effects: a mega-analysis of citalopram and paroxetine in adult depression F Hieronymus, A Lisinski, S Nilsson, E Eriksson Molecular Psychiatry 23 (8), 1731-1736, 2018 | 61 | 2018 |
| Optimizing psychiatric care during the COVID‐19 pandemic MM Madsen, D Dines, F Hieronymus Acta Psychiatrica Scandinavica 142 (1), 70, 2020 | 40 | 2020 |
| Do side effects of antidepressants impact efficacy estimates based on the Hamilton Depression Rating Scale? A pooled patient-level analysis F Hieronymus, A Lisinski, E Eriksson, SD Østergaard Translational psychiatry 11 (1), 249, 2021 | 38 | 2021 |
| One (effect) size does not fit at all: interpreting clinical significance and effect sizes in depression treatment trials F Hieronymus, S Jauhar, SD Østergaard, AH Young Journal of Psychopharmacology 34 (10), 1074-1078, 2020 | 36 | 2020 |
| The complex clinical response to selective serotonin reuptake inhibitors in depression: a network perspective L Boschloo, F Hieronymus, A Lisinski, P Cuijpers, E Eriksson Translational Psychiatry 13 (1), 19, 2023 | 34 | 2023 |
| Item-based analysis of the effects of duloxetine in depression: a patient-level post hoc study A Lisinski, F Hieronymus, J Näslund, S Nilsson, E Eriksson Neuropsychopharmacology 45 (3), 553-560, 2020 | 34 | 2020 |
| Effects of selective serotonin reuptake inhibitors on rating-scale-assessed suicidality in adults with depression J Näslund, F Hieronymus, A Lisinski, S Nilsson, E Eriksson The British Journal of Psychiatry 212 (3), 148-154, 2018 | 33 | 2018 |
| Pre‐diagnostic and post‐diagnostic psychopharmacological treatment of 16 288 patients with bipolar disorder O Köhler‐Forsberg, C Gasse, F Hieronymus, L Petersen, RH Christensen, ... Bipolar disorders 23 (4), 357-367, 2021 | 31 | 2021 |
| Incidence of early anxiety aggravation in trials of selective serotonin reuptake inhibitors in depression J Näslund, F Hieronymus, JF Emilsson, A Lisinski, S Nilsson, E Eriksson Acta Psychiatrica Scandinavica 136 (4), 343-351, 2017 | 31 | 2017 |
| On the application of machine learning techniques to regression problems in sea level studies M Hieronymus, J Hieronymus, F Hieronymus Journal of Atmospheric and Oceanic Technology 36 (9), 1889-1902, 2019 | 30 | 2019 |
| Initial severity of the Positive and Negative Syndrome Scale (PANSS)-30, its main subscales plus the PANSS-6, and the relationship to subsequent improvement and trial dropout … F Hieronymus, CU Correll, SD Østergaard Translational Psychiatry 13 (1), 191, 2023 | 21 | 2023 |
| A novel machine learning based bias correction method and its application to sea level in an ensemble of downscaled climate projections M Hieronymus, F Hieronymus Tellus 75 (1), 2023 | 18 | 2023 |
| Item-level heterogeneous treatment effects of selective serotonin reuptake inhibitors (SSRIs) on depression: Implications for inference, generalizability, and identification JB Gilbert, F Hieronymus, E Eriksson, BW Domingue Epidemiologic Methods 13 (s2), 20240006, 2024 | 15 | 2024 |
| Antipsychotic-placebo separation on the PANSS-6 subscale as compared to the PANSS-30: a pooled participant-level analysis F Hieronymus, P Kølbæk, CU Correll, SD Østergaard npj Schizophrenia 7 (1), 41, 2021 | 14 | 2021 |
| Low SSRI dosing in clinical practice—a register‐based longitudinal study A Lisinski, F Hieronymus, E Eriksson, SM Wallerstedt Acta Psychiatrica Scandinavica 143 (5), 434-443, 2021 | 14 | 2021 |